PCN3: COMPARISON OF COSTS AND EFFECTS OF PROPHYLACTIC PAMIDRONATE FOR THE PREVENTION OF SKELETAL RELATED EVENTS IN PATIENTS WITH ADVANCED BREAST CANCER IN POLAND (COST-EFFECTIVENESS AND COST-UTILITY ANALYSIS)
E OrlewskaVolume:
3
Year:
2000
Language:
english
DOI:
10.1016/s1098-3015(11)70758-6
File:
PDF, 58 KB
english, 2000